Verano Holdings Corp. (VRNO) Financials

VRNO Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 1.7 billion 1.0 billion
Dec. 31, 2025 1.8 billion 1.1 billion
Sept. 30, 2025 1.9 billion 1.0 billion
June 30, 2025 1.9 billion 1.0 billion

VRNO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 3.6 million ?
Dec. 31, 2025 4.5 million ?
Sept. 30, 2025 19.1 million ?
June 30, 2025 431000 3.3 million

VRNO Net Income

No data available :(

VRNO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 74.3 million 385.5 million 89.4 million
Dec. 31, 2025 82.6 million 391.2 million 90.9 million
Sept. 30, 2025 82.5 million 397.4 million 92.9 million
June 30, 2025 68.6 million 399.8 million 105.7 million

VRNO Shares Outstanding

No data available :(

VRNO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 14.7 million - 79.9 million -
Dec. 31, 2025 9.6 million - 85.2 million -
Sept. 30, 2025 7.3 million - 74.8 million -
June 30, 2025 10.5 million - 86.3 million -

VRNO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 205.3 million 112.5 million
Dec. 31, 2025 209.8 million 101.1 million
Sept. 30, 2025 200.6 million 111.2 million
June 30, 2025 202.3 million 89.3 million

VRNO

Price: $1.08

52 week price:
0.46
1.95

Earnings Per Share: -0.99 USD

P/E Ratio: -1.08

Exchange: OQX

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 422.7 million

Links: